Cover: The Benefits of Risk Factor Prevention in Americans Aged 51 Years and Older

The Benefits of Risk Factor Prevention in Americans Aged 51 Years and Older

Published In: American Journal of Public Health, v. 99, no. 11, Nov. 1, 2009, p. 2096-1201

Posted on on January 01, 2009

by Dana P. Goldman, Yuhui Zheng, Federico Girosi, Pierre-Carl Michaud, S. Jay Olshansky, David M. Cutler, John W. Rowe

OBJECTIVES: The authors assessed the potential health and economic benefits of reducing common risk factors in older Americans. METHODS: A dynamic simulation model tracked a national cohort of persons 51 and 52 years of age to project their health and medical spending in prevention scenarios for diabetes, hypertension, obesity, and smoking. RESULTS: The gain in life span from successful treatment of a person aged 51 or 52 years for obesity would be 0.85 years; for hypertension, 2.05 years; and for diabetes, 3.17 years. A 51- or 52-year-old person who quit smoking would gain 3.44 years. Despite living longer, those successfully treated for obesity, hypertension, or diabetes would have lower lifetime medical spending, exclusive of prevention costs. Smoking cessation would lead to increased lifetime spending. The authors used traditional valuations for a life-year to calculate that successful treatments would be worth, per capita, $198018 (diabetes), $137964 (hypertension), $118946 (smoking), and $51750 (obesity). CONCLUSIONS: Effective prevention could substantially improve the health of older Americans, and-despite increases in longevity-such benefits could be achieved with little or no additional lifetime medical spending.

This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.